Diabetes Genetics: Heredity's Role in Type 1 and Type 2 Risk
Genetics significantly influence diabetes susceptibility, but the architecture differs between types:
Type 1 Diabetes (T1D)
- Polygenic: >50 loci; strongest association with HLA-DR3/DR4-DQ8 haplotypes (chromosome 6).
- Concordance: ~50% in identical twins; ~6% in siblings.
- Mechanism: Autoimmune β-cell destruction triggered by environmental factors (viruses, diet, microbiome) in genetically prone individuals.
Type 2 Diabetes (T2D)
- Highly Polygenic: >400 loci (TCF7L2, PPARG, KCNJ11, etc.); each confers small risk (OR 1.1–1.3).
- Heritability: 40–70%; concordance ~70–90% in identical twins.
- Mechanism: Variants affect insulin secretion, insulin action, adipocyte function, incretin signaling.
Clinical Utility
- Genetic testing not routine for T1D/T2D diagnosis.
- Monogenic diabetes (MODY, neonatal diabetes) is diagnosed via genetic testing—impacts treatment (e.g., sulfonylureas for HNF1A/4A MODY).
- Polygenic risk scores emerging for risk stratification but not yet standard of care.
Family history remains the most practical clinical genetic tool.
Genetic Disorders - Related Articles
- PANDAS: Understanding Pediatric Autoimmune Disorders
- Agent Orange Exposure and Birth Defects: Understanding the Risks
- Mononucleosis in Your 50s: Symptoms, Risks & What to Do
- Tetralogy of Fallot: Genetic Basis, Inheritance, and Counseling
- Cleft Lip & Palate Treatment: Understanding Causes & Repair
- SIADH: Who's at Risk? (Lung/Heart Disease, Cancer, Infections, Certain Meds)
- Understanding Lipid Metabolism Disorders: Causes, Symptoms & Management
